Abstract:Question Does germline genetic variation influence the risk of a person developing an in situ or an invasive melanoma? Findings In this genome-wide association study meta-analysis of in situ and invasive melanoma risk, there was much shared genetic architecture influencing both melanoma classifications. However, polygenic risk scores (PRS) reflecting the genetic difference between the 2 classifications were significantly higher in invasive melanoma groups than in situ melanoma groups, suggesting germline genetics plays a role in the differential melanoma diagnosis. Meaning PRS may be used to stratify people based on their risk of invasive melanoma, which could inform future melanoma screening practices without exacerbating melanoma overdiagnosis. Importance It is unknown whether germline genetic factors influence in situ melanoma risk differently than invasive melanoma risk. Objective To determine whether differences in risk of in situ melanoma and invasive melanoma are heritable. Design, Setting, and Participants Three genome-wide association study meta-analyses were conducted of in situ melanoma vs controls, invasive melanoma vs controls, and in situ vs invasive melanoma (case-case) using 4 population-based genetic cohorts: the UK Biobank, the FinnGen cohort, the QSkin Sun and Health Study, and the Queensland Study of Melanoma: Environmental and Genetic Associations (Q-MEGA). Melanoma status was determined using International Statistical Classification of Diseases and Related Health Problems codes from cancer registry data. Data were collected from 1987 to 2022, and data were analyzed from September 2022 to June 2023. Exposure In situ and invasive cutaneous melanoma. Main Outcomes and Measures To test whether in situ and invasive melanoma have independent heritable components, genetic effect estimates were calculated for single-nucleotide variants (SNV; formerly single-nucleotide polymorphisms) throughout the genome for each melanoma. Then, SNV-based heritability was estimated, the genetic correlation between melanoma subtypes was assessed, and polygenic risk scores (PRS) were generated for in situ vs invasive status in Q-MEGA participants. Results A total of 6 genome-wide significant loci associated with in situ melanoma and 18 loci with invasive melanoma were identified. A strong genetic correlation (genetic r = 0.96; 95% CI, 0.76-1.15) was observed between the 2 classifications. Notably, loci near IRF4 , KLF4 , and HULC had significantly larger effects for in situ melanoma compared with invasive melanoma, while MC1R had a significantly larger effect on invasive melanoma compared with in situ melanoma. Heritability estimates were consistent for both, with in situ melanoma heritability of 6.7% (95% CI, 4.1-9.3) and invasive melanoma heritability of 4.9% (95% CI, 2.8-7.2). Finally, a PRS, derived from comparing invasive melanoma with in situ melanoma genetic risk, was on average significantly higher in participants with invasive melanoma (odds ratio per 1-SD increase in PRS, 1.43; 95% CI, 1.16-1.77). Conclusions and Relevance There is much shared genetic architecture between in situ melanoma and invasive melanoma. Despite indistinguishable heritability estimates between the melanoma classifications, PRS suggest germline genetics may influence whether a person gets in situ melanoma or invasive melanoma. PRS could potentially help stratify populations based on invasive melanoma risk, informing future screening programs without exacerbating the current burden of melanoma overdiagnosis.

Germline Cancer Susceptibility in Individuals with Melanoma

Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.

Does the Germline Genome Encode for the Invasiveness of a Cutaneous Melanoma?

Abstract 7334: Germline mutations in cancer susceptibility genes in patients with mucosal melanoma

Prevalence of CDKN2A, CDK4, POT1, BAP1, MITF, ATM, and TERT Pathogenic Variants in a Single-Center Retrospective Series of Patients With Melanoma and Personal or Family History Suggestive of Genetic Predisposition

Genetic testing for familial melanoma

Abstract 5050: Germline variants in CDKN2A wild-type melanoma prone families

Exploring the Germline Genetics of In Situ and Invasive Cutaneous Melanoma

Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotype

Unveiling the genetic landscape of hereditary melanoma: From susceptibility to surveillance

Most common 'sporadic' cancers have a significant germline genetic component.

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes.

Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer

Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer

A Clinical Guide to Hereditary Cancer Panel Testing: Evaluation of Gene-Specific Cancer Associations and Sensitivity of Genetic Testing Criteria in a Cohort of 165,000 High-Risk Patients.

Genome-wide Association Meta-Analyses Combining Multiple Risk Phenotypes Provide Insights into the Genetic Architecture of Cutaneous Melanoma Susceptibility

P069 Familial malignant melanoma: CDKN2A mutation-positive family tree

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.